Iobenguane

CHEMBL818 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
275.1 g/mol
LogP
1.0
Phase
4

This compound is a guanethidine analogue that, when labeled with radioactive iodine, is used for imaging or treating tumors of the adrenal medulla (pheochromocytoma) and related neuroendocrine tumors. It accumulates in these tumors due to active uptake by norepinephrine transporters. The radioactive form allows both diagnostic scanning and targeted radiation therapy.

分子量

275.0900 g/mol

LogP

1.00

TPSA

64.40 Ų

リピンスキーの五則

適合

治療領域

作用機序

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

機序

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

N=C(N)NCc1cccc(I)c1

InChI

InChI=1S/C8H10IN3/c9-7-3-1-2-6(4-7)5-12-8(10)11/h1-4H,5H2,(H4,10,11,12)

Molecular Formula

C8H10IN3

HBD / HBA

2 / 1

回転可能結合数

2

重原子数

12

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

This compound is a guanethidine analogue that, when labeled with radioactive iodine, is used for imaging or treating tumors of the adrenal medulla (pheochromocytoma) and related neuroendocrine tumors. It accumulates in these tumors due to active uptake by norepinephrine transporters. The radioactive form allows both diagnostic scanning and targeted radiation therapy.

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Yes, Iobenguane is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL818. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 60860. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.